Related Experiment Video
Updated: May 15, 2026

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Development of acute dystonia in three brothers due to metoclopramide
Ibrahim Silfeler1, Vefik Arica, Secil Arica
1Department of Pediatrics, School of Medicine, Mustafa Kemal University, Hatay, Turkey.
Abstract:
One of the agents that cause dystonic reactions is metoclopramide. In this study, we presented three individuals of the same family who were admitted to our hospital while receiving the treatment of metoclopramide because of developing acute dystonic reaction. Appropriate doses of metoclopramide therapy had begun to all brothers with a diagnosis of gastroenteritis. After receiving the first dose of medication, acute dystonia was observed within half an hour in these brothers who used metoclopramide. Thus, if there is a patient who developed acute dystonia in the same family due to metoclopramide, avoiding from use of metoclopramide will be beneficial for other members of the family.
Insights
Metoclopramide can cause acute dystonic reactions. In one family, three brothers experienced this adverse drug reaction after metoclopramide treatment, suggesting a potential genetic predisposition.
Area of Science:
- Neurology
- Pharmacology
- Genetics
Background:
- Metoclopramide is a commonly prescribed medication for gastrointestinal issues.
- Dystonic reactions are a known, albeit uncommon, side effect of metoclopramide.
- Family history can play a role in adverse drug reactions.
Observation:
- Three brothers from the same family developed acute dystonic reactions shortly after receiving their first dose of metoclopramide.
- The patients were treated with metoclopramide for gastroenteritis.
- Symptoms of acute dystonia appeared within 30 minutes of medication administration.
Findings:
- The simultaneous occurrence of acute dystonic reactions in multiple siblings treated with metoclopramide suggests a potential familial susceptibility.
- This case highlights a possible genetic link or shared environmental factor influencing metoclopramide-induced dystonia.
Implications:
- Healthcare providers should consider metoclopramide's risk of dystonic reactions, especially in patients with a family history.
- If one family member experiences a metoclopramide-induced dystonic reaction, caution is advised when prescribing it to other family members.
- Further research into the genetic factors influencing metoclopramide pharmacodynamics may be warranted.
Related Concept Videos
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Alterations in Muscle Tone ll
Alterations in Muscle Tone lll
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...

